eNauka - pregled
Pregled prema Autor Yavrom, S
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2023 | HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome | Tobias, Joshua; Kundi, Michael; Garner-Spitzer, E; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran G
Nixon, B; Yavrom, S; Ede, NJ; Wiedermann, Ursula;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2023 | HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome | Tobias, Joshua; Kundi, Michael; Garner-Spitzer, E; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran G
Nixon, B; Yavrom, S; Ede, NJ; Wiedermann, Ursula;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |